系統，大腸直腸瘜肉，RNA標記及血紅素檢測
PMA 核准號：P230001 · 2026-09-08
廣告
器材摘要
System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection is the device name listed in this FDA 510(k) record. The listed applicant is Geneoscopy, Inc.. It received FDA 510(k) clearance on 2026-09-08. The device is classified under product code SBB. It was reviewed by the PA advisory panel.
常見問題
What is the System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection?
System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection is a medical device that received FDA 510(k) clearance on 2026-09-08. The listed applicant is Geneoscopy, Inc..
When did System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection receive FDA 510(k) clearance?
The clearance date for System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection can be found in the official FDA records.
誰是System、大腸直腸瘜肉、RNA標記和血紅素檢測的登記申請人？
The FDA 510(k) record lists Geneoscopy, Inc. as the applicant. This does not by itself establish the device manufacturer.
FDA產品代碼為System, 大腸直腸惡性腫瘤, RNA標記和血紅素檢測是什麼？
FDA產品代碼為System, 大腸直腸惡性腫瘤, RNA標記和血紅素檢測的為SBB。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告